Patent assignee · US · COMPANY

Urocor, Inc.

🏢 View company profile →
13Patents
0Active
13Granted
34Portfolio score

Filing activity: Jun 3, 1994 → Sep 11, 2000

Most-cited patents

PatentTitleAreaCited byStatus
US5882864A Biomarkers and targets for diagnosis, prognosis and management of prostate disease Chemistry; Metallurgy 135 Expired
US5972615A Biomarkers and targets for diagnosis, prognosis and management of prostate disease Emerging Cross-Sectional Technologies 113 Expired
US6171796A Biomarkers and targets for diagnosis prognosis and management of prostate disease Emerging Cross-Sectional Technologies 87 Expired
US6463438B1 Neural network for cell image analysis for identification of abnormal cells Physics 72 Expired
US6218529A Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer Chemistry; Metallurgy 70 Expired
US6190857A Diagnosis of disease state using MRNA profiles in peripheral leukocytes Physics 39 Expired
US5989811A Sextant core biopsy predictive mechanism for non-organ confined disease status Emerging Cross-Sectional Technologies 36 Expired
US5861248A Biomarkers for detection of prostate cancer Chemistry; Metallurgy 12 Expired
US6090559A Biomarkers for the detection of prostate cancer Chemistry; Metallurgy 12 Expired
US6369195B1 Prostate-specific gene for diagnosis, prognosis and management of prostate cancer Emerging Cross-Sectional Technologies 10 Expired
US5856112A Method for selectively inducing biomarker expression in urologic tumor tissue for diagnosis and treatment thereof Chemistry; Metallurgy 10 Expired
US7332270B1 Diagnosis of disease state using mRNA profiles in peripheral leukocytes Physics 1 Expired
US6156515A Prostate-specific gene for diagnosis, prognosis and management of prostate cancer Emerging Cross-Sectional Technologies 0 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.